According to Cancer Research UK, more than one in three people in the UK will develop cancer during their life time. The Parsortix system from ANGLE enables a liquid biopsy by capturing rare, circulating tumour cells (CTCs) from patient blood. Captured CTCs are a valuable source of information and can be used to inform and optimise patient care.
“We needed a partner that could provide a complete ISO13485 manufacturing, service and support solution; since as a new-to-market product that infrastructure did not pre-exist. Our experience with Cogent is of a team that take pride and ownership in the product and work hard to optimise and control the manufacturing processes to mirror the significance of the device they are producing. The thing you can’t measure at supplier selection stage, the passion and expertise of the people, is the evidence I can see, that we can depend on the team at Cogent.”